Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3085 (LINC03085)
- Target
- LINC03085
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 3085 (LINC03085, also called AC073534.2) is a long intergenic non-coding RNA gene in humans, meaning it encodes a large RNA transcript (>200 nucleotides) that does not overlap annotated protein-coding genes and does not encode a protein[3][5]. Like other lincRNAs, it may play a role in regulation of chromatin architecture, transcription, and fine-tuning of gene expression in a tissue-specific manner, though its precise biological function, disease involvement, and clinical relevance remain uncharacterized. Unlike classic therapeutic targets, no drugs or diagnostic tools specifically interact with this RNA, and it is not classified under receptor, enzyme, transporter, or similar molecular families.[1][3][5]
- Other names
- LINC03085AC073534.2
02
Mechanism of action
None reported (No mechanism described for drugs targeting LINC03085; not a conventional drug target.)
03
Biological functions
Chromatin remodelingRegulation of transcriptionPossibly acts as a scaffold for chromatin or protein complexesPotential fine-tuner of neighboring gene expression
04
Disease associations
Other (no direct, published role in cancer, inflammation, or other named diseases for LINC03085 as of current research; many lincRNAs are implicated in cancer or epigenetic disorders, but LINC03085 has not been specifically associated)
05
Safety considerations
None reported (No safety concerns or therapeutic challenges have been described, as LINC03085 is not a current drug target.)
06
Interacting drugs
None reported (No drugs are known to directly target LINC03085.)
07
Biomarkers
None reported (LINC03085 is not known to be used as a biomarker for patient selection or disease monitoring.)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 3085 (LINC03085).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3085 (LINC03085).